Shanley John F 4
4 · CONOR MEDSYSTEMS INC · Filed Feb 2, 2007
Insider Transaction Report
Form 4
Shanley John F
DirectorChief Technology Officer
Transactions
- Disposition to Issuer
Common Stock
2007-02-01$33.50/sh−2,000$67,000→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2007-02-01$32.31/sh−315,000$10,177,650→ 0 totalExercise: $1.19Exp: 2014-08-11→ Common Stock (315,000 underlying) - Disposition to Issuer
Common Stock
2007-02-01$33.50/sh−54,600$1,829,100→ 0 total(indirect: See Footnote) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2007-02-01$11.46/sh−80,000$916,800→ 0 totalExercise: $22.04Exp: 2016-01-20→ Common Stock (80,000 underlying) - Disposition to Issuer
Common Stock
2007-02-01$33.50/sh−1,130,200$37,861,700→ 0 total(indirect: See Footnote) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2007-02-01$33.21/sh−157,500$5,230,575→ 0 totalExercise: $0.29Exp: 2013-11-18→ Common Stock (157,500 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2007-02-01$17.62/sh−60,000$1,057,200→ 0 totalExercise: $15.88Exp: 2015-05-09→ Common Stock (60,000 underlying)
Footnotes (6)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated November 16, 2006, among Conor Medsystems, Inc., Johnson & Johnson and Cypress Acquisition Sub, Inc., a wholly owned subsidiary of Johnson & Johnson (the "Merger Agreement"), each issued and outstanding share of common stock was automatically canceled and converted into the right to receive a per share amount equal to $33.50 in cash, without interest.
- [F2]Shares were held by the Shanley Family Trust dated September 10, 2004.
- [F3]Shares were held by the Conor E. Shanley Trust dated September 4, 2003.
- [F4]Shares were held by the John F. Shanley IV Trust dated September 4, 2003.
- [F5]Shares were held by the Ryan J. Shanley Trust dated September 4, 2003.
- [F6]This option, which vested in increments of one forty-eighth of the total shares subject to the option each month, was canceled pursuant to the terms of the Merger Agreement, in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.